Skip to main content

Table 5 Median values and median percentage change from baseline for serum lipid profiles (mITT population)

From: Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women

Lipid

Exemestane (n= 20)

Letrozole (n= 20)

Anastrozole (n= 19)

Placebo (n= 20)

LDL-C (mmol/L)

   Baseline

4.2

4.2

4.2

3.8

   Week 12, % change

-11

-4.5

-12

-6.1

   Week 24, % change

-2.6

-4.2

-3.0

2.4

   Week 36, % change

1.9

0.25

-5.7

-5.8

HDL-C (mmol/L)

   Baseline, median

1.4

1.5

1.4

1.4

   Week 12, % change

-4.4

9.0

1.7

-3.5

   Week 24, % change

-13

-2.4

-4.4

-6.3

   Week 36, % change

-6.9

-2.4

-2.5

-6.8

Total cholesterol (mmol/L)

   Baseline, median

6.1

6.1

6.3

5.9

   Week 12, % change

-6.8

-1.8

-3.7

-2.6

   Week 24, % change

0.78

1.2

-0.68

0.75

   Week 36, % change

1.3

-1.9

-5.8

-6.4

Triglycerides (mmol/L)

   Baseline, median

1.1

1.2

1.2

1.0

   Week 12, % change

-21

6.6

-10

-1.6

   Week 24, % change

1.7

4.6

6.3

-7.0

   Week 36, % change

-1.1

-5.4

-3.5

-0.28

  1. HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; mITT = modified intent to treat.